Literature DB >> 16786139

PEA3 cooperates with c-Jun in regulation of HER2/neu transcription.

Koshi Matsui1, Kazuhito Sugimori, Hiraku Motomura, Naoko Ejiri, Kazuhiro Tsukada, Isao Kitajima.   

Abstract

HER2/neu overexpressing breast tumors exhibit an increase in polyomavirus enhancer activator 3 (PEA3) expression. We examined the relationship between HER2/neu transcriptional activation and PEA3 in cooperation with c-Jun. HER2/neu promoter activity was decreased by deleting PEA3 binding site, and was downregulated when the PEA3 binding site was mutated. PEA3 and c-Jun each weakly enhanced luciferase expression of the HER2/neu promoter. However, the HER2/neu promoter response to PEA3 was considerably enhanced by c-Jun. Thus, we examined the interaction of PEA3 with c-Jun by the two-hybrid system, the transcriptional activity of PEA3 was specifically enhanced by c-Jun. When PEA3, c-Jun and coactivator p300 were cotransfected in MCF7 cells, the transcriptional activity of HER2/neu was increased by up to 20-fold. PEA3 and c-Jun-induced transcription of HER2/neu promoter was repressed by cotransfection of the dominant negative of p300. These results suggest that PEA3 and c-Jun stimulated synergistically the HER2/neu gene transcription with p300.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16786139

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

Review 1.  The HER2 Signaling Network in Breast Cancer--Like a Spider in its Web.

Authors:  A Dittrich; H Gautrey; D Browell; A Tyson-Capper
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-12-28       Impact factor: 2.673

2.  PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma.

Authors:  R Keld; B Guo; P Downey; R Cummins; C Gulmann; Y S Ang; A D Sharrocks
Journal:  Br J Cancer       Date:  2011-06-14       Impact factor: 7.640

3.  NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.

Authors:  Anthony G Clementz; Allison Rogowski; Kinnari Pandya; Lucio Miele; Clodia Osipo
Journal:  Breast Cancer Res       Date:  2011-06-14       Impact factor: 6.466

4.  Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signaling.

Authors:  Kristin Wollenick; Jun Hu; Glen Kristiansen; Peter Schraml; Hubert Rehrauer; Utta Berchner-Pfannschmidt; Joachim Fandrey; Roland H Wenger; Daniel P Stiehl
Journal:  Nucleic Acids Res       Date:  2011-11-10       Impact factor: 16.971

5.  c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression.

Authors:  Michael A Cantrell; Nancy D Ebelt; Adam D Pfefferle; Charles M Perou; Carla Lynn Van Den Berg
Journal:  Oncotarget       Date:  2015-05-20

6.  The -553 T/A polymorphism in the promoter region of the FGF2 gene is associated with increased breast cancer risk in Polish women.

Authors:  Jan Rykala; Karolina Przybylowska; Ireneusz Majsterek; Grazyna Pasz-Walczak; Andrzej Sygut; Adam Dziki; Piotr Kuna
Journal:  Arch Med Sci       Date:  2014-01-23       Impact factor: 3.318

7.  Hepatitis B virus X upregulates HuR protein level to stabilize HER2 expression in hepatocellular carcinoma cells.

Authors:  Chao-Ming Hung; Wei-Chien Huang; Hsiao-Lin Pan; Pei-Hsuan Chien; Chih-Wen Lin; Lei-Chin Chen; Yu-Fong Chien; Ching-Chiao Lin; Kar-Hee Leow; Wen-Shu Chen; Jhen-Yu Chen; Chien-Yi Ho; Pao-Sheng Hou; Yun-Ju Chen
Journal:  Biomed Res Int       Date:  2014-02-27       Impact factor: 3.411

8.  MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models.

Authors:  Zheng Xue; Daniel J Vis; Alejandra Bruna; Tonci Sustic; Sake van Wageningen; Ankita Sati Batra; Oscar M Rueda; Evert Bosdriesz; Carlos Caldas; Lodewyk F A Wessels; René Bernards
Journal:  Cell Res       Date:  2018-05-24       Impact factor: 25.617

9.  Pea3 transcription factors and wnt1-induced mouse mammary neoplasia.

Authors:  Rebecca Baker; Claire V Kent; Rachel A Silbermann; John A Hassell; Lawrence J T Young; Louise R Howe
Journal:  PLoS One       Date:  2010-01-22       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.